Michele Kearney's Nuclear Wire: Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults | National Institutes of Health (NIH)

Michele Kearney's Nuclear Wire

Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities

Tuesday, September 29, 2020

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults | National Institutes of Health (NIH)

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults | National Institutes of Health (NIH): A Phase 1 clinical trial enrolled 40 healthy volunteers.

Michele Kearney at 6:45 PM

No comments:

Post a Comment

View web version

Powered by Blogger.